.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Neovascular age-related macular degeneration (nAMD) demands consistent anti-VEGF therapy, but faricimab for nAMD care presents a transformative approach for overburdened clinics. Indeed, faricimab for nAMD care offers long-term durability that reduces treatment frequency. Consequently, healthcare providers can now address capacity constraints more effectively. Moreover, recent data from a UK-based microsimulation model highlight how faricimab enhances service delivery. In addition, this performance significantly exceeds that of biosimilar aflibercept 2 mg.
Specifically, the study demonstrated that faricimab slashed delayed visits by 97.4% in the base case analysis. Furthermore, loading phase completion improved by 54.1 percentage points. Therefore, more patients receive the full initial treatment necessary for vision preservation. Similarly, the research compared two different payer strategies. For example, a "treatment choice" policy yielded better operational metrics than a "strict biosimilar mandate." Thus, allowing clinicians to choose durable options leads to higher care quality.
Notably, faricimab showed lower acquisition costs than competitors. In contrast, the therapy generated additional savings through reduced service utilization. Ultimately, these efficiencies allow health systems to treat more patients. As a result, clinics can maintain higher standards while lowering costs. Because faricimab requires fewer injections, it also reduces litigation-related expenses. In conclusion, durable therapies provide both clinical and economic value and enhance sustainability.
Faricimab improves efficiency by extending the interval between injections, which reduces the total number of patient visits and frees up clinical staff to treat more individuals.
The simulation model showed that using faricimab reduced delayed visits by over 97% compared to biosimilar aflibercept 2 mg in a capacity-constrained setting.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. While we strive for accuracy, healthcare professionals should always verify information with primary sources. Refer to the latest local and national guidelines for clinical practice.
References
Gil-Rojas Y et al. Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care. Ophthalmol Ther. 2026 Mar 19. doi: 10.1007/s40123-026-01346-9. PMID: 41854807.
Roche Pharma India. Roche Pharma Introduces Vabysmo To Treat Vision Impairment in the Indian Market. March 2024.
Heier JS et al. Efficacy, durability, and safety of faricimab in neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022; 399(10326):729-740.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study shows how faricimab improves service efficiency and care quality in nAMD by reducing injection frequency and clinic delays compared to afliberce...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
